GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

Myth 1: Semaglutide is just another diet pill One of the most widespread myths is that semaglutide is just another fad diet pill. This couldn’t be further from the truth. Semaglutide is not a ...

The most advanced of these pills include a form of semaglutide, the active ingredient in Ozempic and Wegovy, being developed ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...

Novo Nordisk, which is developing two weight-loss pills including an oral version of semaglutide, is currently Europe’s most valuable company with a valuation of £460bn, three times what it was ...

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

A once-daily pill version of the drug popularly known as Ozempic is one step closer to market. Drugmaker Novo Nordisk announced the results of a large, phase 3 trial of oral semaglutide on Monday.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like semaglutide (the active ingredient in Ozempic and Wegovy).

Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...